• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自含ELR的CXC趋化因子的新型抗血管生成肽。

Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.

作者信息

Karagiannis Emmanouil D, Popel Aleksander S

机构信息

Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

J Cell Biochem. 2008 Jul 1;104(4):1356-63. doi: 10.1002/jcb.21712.

DOI:10.1002/jcb.21712
PMID:18307172
Abstract

Angiogenesis is tightly regulated by numerous endogenous pro- and anti-angiogenic proteins and peptides. Among these are the CXC chemokines, a set of multifunctional peptides. CXC chemokines containing the ELR motif act as pro-angiogenic agents by regulating both endothelial cell proliferation and migration. Here we show that a set of six 22-24-amino acid peptides derived from the pro-angiogenic ELR-containing CXC chemokines exhibit notable anti-proliferative and anti-migratory activity in vitro; we call these peptides chemokinostatins. The ability of the identified peptides to inhibit the basic components of angiogenesis even though they are derived from pro-angiogenic proteins contributes towards the understanding of the diverse role of the CXC chemokine family in angiogenesis.

摘要

血管生成受到多种内源性促血管生成和抗血管生成蛋白及肽的严格调控。其中包括CXC趋化因子,这是一组多功能肽。含有ELR基序的CXC趋化因子通过调节内皮细胞的增殖和迁移而作为促血管生成因子发挥作用。在此,我们表明,一组源自含ELR的促血管生成CXC趋化因子的六个22 - 24个氨基酸的肽在体外表现出显著的抗增殖和抗迁移活性;我们将这些肽称为趋化因子抑制素。尽管所鉴定的肽源自促血管生成蛋白,但它们抑制血管生成基本成分的能力有助于理解CXC趋化因子家族在血管生成中的多种作用。

相似文献

1
Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.源自含ELR的CXC趋化因子的新型抗血管生成肽。
J Cell Biochem. 2008 Jul 1;104(4):1356-63. doi: 10.1002/jcb.21712.
2
Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.源自CCN家族含I型血小板反应蛋白重复序列蛋白的肽可抑制内皮细胞的增殖和迁移。
Int J Biochem Cell Biol. 2007;39(12):2314-23. doi: 10.1016/j.biocel.2007.06.018. Epub 2007 Jul 30.
3
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.CXC趋化因子受体2(CXCR2)是ELR+CXC趋化因子诱导的血管生成活性的假定受体。
J Immunol. 2000 Nov 1;165(9):5269-77. doi: 10.4049/jimmunol.165.9.5269.
4
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.CXC趋化因子/CXCR2生物学轴在体外和体内均促进胰腺癌血管生成。
Int J Cancer. 2009 Sep 1;125(5):1027-37. doi: 10.1002/ijc.24383.
5
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.监测多发性骨髓瘤患者血清中 ELR+CXC 趋化因子水平及其与微血管密度和血管生成生长因子的关系。
Cytokine. 2011 Dec;56(3):616-20. doi: 10.1016/j.cyto.2011.08.034. Epub 2011 Sep 21.
6
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.ELR基序在CXC趋化因子介导的血管生成中的功能作用。
J Biol Chem. 1995 Nov 10;270(45):27348-57. doi: 10.1074/jbc.270.45.27348.
7
CXC chemokines in angiogenesis.血管生成中的CXC趋化因子
J Leukoc Biol. 2000 Jul;68(1):1-8.
8
CXC chemokines in angiogenesis relevant to chronic fibroproliferation.与慢性纤维增生相关的血管生成中的CXC趋化因子。
Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):23-6. doi: 10.2174/1568010053622902.
9
Anti-angiogenic peptides identified in thrombospondin type I domains.在I型血小板反应蛋白结构域中鉴定出的抗血管生成肽。
Biochem Biophys Res Commun. 2007 Jul 20;359(1):63-9. doi: 10.1016/j.bbrc.2007.05.041. Epub 2007 May 14.
10
ELR+ CXC chemokines in human milk.人乳中的ELR+ CXC趋化因子
Cytokine. 2003 Nov 7;24(3):91-102. doi: 10.1016/j.cyto.2003.07.002.

引用本文的文献

1
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth.趋化因子衍生的溶瘤肽诱导免疫原性癌细胞死亡并显著抑制肿瘤生长。
Cell Death Discov. 2024 Apr 2;10(1):161. doi: 10.1038/s41420-024-01932-5.
2
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth.趋化因子衍生的溶瘤肽诱导免疫原性癌细胞死亡并显著抑制肿瘤生长。
Res Sq. 2023 Oct 3:rs.3.rs-3335225. doi: 10.21203/rs.3.rs-3335225/v1.
3
Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
肽-配体偶联物在靶向肿瘤细胞中的最新进展和应用。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15249-15273. doi: 10.1007/s00432-023-05144-9. Epub 2023 Aug 15.
4
The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer.CD26对趋化因子进行翻译后修饰在癌症中的作用
Cancers (Basel). 2021 Aug 24;13(17):4247. doi: 10.3390/cancers13174247.
5
Design and Synthesis of Novel Triazole-based Peptide Analogues as Anticancer Agents.新型基于三唑的肽类似物作为抗癌剂的设计与合成
Iran J Pharm Res. 2019 Summer;18(3):1299-1308. doi: 10.22037/ijpr.2019.111722.13320.
6
Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.趋化因子衍生肽:新型抗菌和抗肿瘤药物。
Int J Mol Sci. 2015 Jun 8;16(6):12958-85. doi: 10.3390/ijms160612958.
7
Cancer treatment using peptides: current therapies and future prospects.使用肽进行癌症治疗:当前疗法与未来前景。
J Amino Acids. 2012;2012:967347. doi: 10.1155/2012/967347. Epub 2012 Dec 20.
8
Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.IV 型胶原和 CXC 趋化因子衍生的抗血管生成肽抑制神经胶质瘤异种移植物生长。
Anticancer Drugs. 2012 Aug;23(7):706-12. doi: 10.1097/CAD.0b013e3283531041.
9
Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.新型肽特异性定量构效关系(QSAR)分析在具有抗血管生成活性的胶原 IV 肽中的应用。
J Med Chem. 2011 Oct 13;54(19):6492-500. doi: 10.1021/jm200114f. Epub 2011 Sep 13.
10
Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins.胶原蛋白、CXC 趋化因子和富含血栓反应蛋白结构域蛋白之间的血管生成相关串扰。
Ann Biomed Eng. 2011 Aug;39(8):2213-22. doi: 10.1007/s10439-011-0325-2. Epub 2011 May 18.